Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VAT study: VZV vaccine to induce antitumor immunity in adult T-cell leukemia/lymphoma
jRCTs051180107Completed
- Sponsor
- Research Foundation for Microbial Diseases of Osaka University
- Start
- May 2016
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label trial of varicella vaccine in adult T-cell leukemia-lymphoma (ATLL) (2 arms), sponsored by Research Foundation for Microbial Diseases of Osaka University. Primary endpoint: Induction of anti-HTLV-1 Tax-specific cytotoxic T lymphocytes. Started May 2016; status: completed.
02
Drugs
varicella vaccine
03
Conditions
adult T-cell leukemia-lymphoma (ATLL)
Beyond the preview
Go deeper on jRCTs051180107.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051180107.